Bajaj HealthCare Limited (BOM:539872)
321.90
-4.25 (-1.30%)
At close: Aug 21, 2026
Bajaj HealthCare Revenue
Bajaj HealthCare had revenue of 1.66B INR in the quarter ending June 30, 2026, with 11.28% growth. This brings the company's revenue in the last twelve months to 6.28B, up 12.27% year-over-year. In the fiscal year ending March 31, 2026, Bajaj HealthCare had annual revenue of 6.11B with 12.61% growth.
Revenue (ttm)
6.28B
Revenue Growth
+12.27%
P/S Ratio
1.73
Revenue / Employee
6.84M
Employees
918
Market Cap
10.84B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.11B | 684.29M | 12.61% |
| Mar 31, 2025 | 5.43B | 691.85M | 14.61% |
| Mar 31, 2024 | 4.73B | -1.72B | -26.69% |
| Mar 31, 2023 | 6.46B | -340.94M | -5.01% |
| Mar 31, 2022 | 6.80B | 229.06M | 3.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 25.24B |
| NGL Fine-Chem | 5.36B |
| Sai Parenteral's | 5.26B |
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Anlon Healthcare | 2.26B |
| Gujarat Themis Biosyn | 1.74B |
| Influx Healthtech | 1.47B |
| Panchsheel Organics | 1.08B |
Bajaj HealthCare News
- 7 months ago - Bajaj Healthcare shares rise over 3% as Q3 revenue jumps 31.3% YoY to Rs 161.2 crore, net profit up 34.2% - Business Upturn
- 11 months ago - Bajaj Healthcare shares jump nearly 3% after CDSCO approval for Phase III trials of insomnia drug Suvorexant - Business Upturn
- 1 year ago - Why is Bajaj Healthcare stock falling despite 66% jump in Q1 profit? Explained - Business Upturn
- 1 year ago - Bajaj Healthcare shares rise nearly 3% as company acquires GenRx Pharmaceuticals to strengthen manufacturing footprint - Business Upturn
- 1 year ago - Bajaj Healthcare shares rise 5% in weak market as Q3 revenue jumps 13% YoY - Business Upturn
- 1 year ago - Corporate Earnings to Watch on February 11: Lupin, Vodafone Idea, Berger Paints, IRCTC, SAIL, and More - Business Upturn
- 1 year ago - Bajaj Healthcare secures DCGI approval to manufacture Pimavanserin in India - Business Upturn
- 1 year ago - Bajaj Healthcare shares surge 12% after securing exclusive rights for Magtein® in India - Business Upturn